Tianyi Junli Capital Fund Manager Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Type

Private Equity Firm

Location

Guangzhou Guangdong China

Alternative Asset Classes

Established

2013

Firm Ownership

Independent Firm

Investment Team Staff

Total Staff

Tianyi Junli Capital is a Chinese private equity firm that manages buyout funds that target domestic pharmaceutical firms. In 2014, Guangzhou Tianyi Junli Investment Management launched Tianyi Lummy Pharmaceutical Industry M&A Fund as a co-GP alongside Chongqing Tianyi Weiye Pharmaceutical Investment Management. It also invests in venture projects.

Asset Class	No. of Funds Currently Managed	Strategies
Private Equity	-	Buyout, Early Stage: Seed
Real Estate	-	-
Private Debt	-	-
Infrastructure	-	-
Natural Resources	-	-

Asset Class	No. of Funds Currently Managed	AuM	Date of AuM	Strategies
Hedge Funds	0			-

Want to see more?

Request a demo for full access to this profile.

Known Decision Makers

Showing 0 of 0 known decision makers at Tianyi Junli Capital

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Tianyi Junli Capital